These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12543719)

  • 1. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.
    Luttun A; Tjwa M; Carmeliet P
    Ann N Y Acad Sci; 2002 Dec; 979():80-93. PubMed ID: 12543719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders.
    Autiero M; Luttun A; Tjwa M; Carmeliet P
    J Thromb Haemost; 2003 Jul; 1(7):1356-70. PubMed ID: 12871269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of placental growth factor.
    De Falco S; Gigante B; Persico MG
    Trends Cardiovasc Med; 2002 Aug; 12(6):241-6. PubMed ID: 12242046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness.
    Athanassiades A; Lala PK
    Placenta; 1998 Sep; 19(7):465-73. PubMed ID: 9778119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
    Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
    Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
    Kumazaki K; Nakayama M; Suehara N; Wada Y
    Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The placenta growth factor in skin angiogenesis.
    Odorisio T; Cianfarani F; Failla CM; Zambruno G
    J Dermatol Sci; 2006 Jan; 41(1):11-9. PubMed ID: 16216466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts.
    Taylor AP; Goldenberg DM
    Mol Cancer Ther; 2007 Feb; 6(2):524-31. PubMed ID: 17308051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
    Shih SC; Ju M; Liu N; Smith LE
    J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
    Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
    Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors.
    Lacal PM; Graziani G
    Pharmacol Res; 2018 Oct; 136():97-107. PubMed ID: 30170190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
    Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
    Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.
    Shibuya M
    J Biochem; 2013 Jan; 153(1):13-9. PubMed ID: 23172303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of placental growth factor in the induction of inflammation and edema formation.
    Oura H; Bertoncini J; Velasco P; Brown LF; Carmeliet P; Detmar M
    Blood; 2003 Jan; 101(2):560-7. PubMed ID: 12393422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.